miRNA-Based Rapid Differentiation of Purified Neurons from hPSCs Advancestowards Quick Screening for Neuronal Disease Phenotypes In Vitro
Open Access
- 25 February 2020
- Vol. 9 (3), 532
- https://doi.org/10.3390/cells9030532
Abstract
Obtaining differentiated cells with high physiological functions by an efficient, but simple and rapid differentiation method is crucial for modeling neuronal diseases in vitro using human pluripotent stem cells (hPSCs). Currently, methods involving the transient expression of one or a couple of transcription factors have been established as techniques for inducing neuronal differentiation in a rapid, single step. It has also been reported that microRNAs can function as reprogramming effectors for directly reprogramming human dermal fibroblasts to neurons. In this study, we tested the effect of adding neuronal microRNAs, miRNA-9/9*, and miR-124 (miR-9/9*-124), for the neuronal induction method of hPSCs using Tet-On-driven expression of the Neurogenin2 gene (Ngn2), a proneural factor. While it has been established that Ngn2 can facilitate differentiation from pluripotent stem cells into neurons with high purity due to its neurogenic effect, a long or indefinite time is required for neuronal maturation with Ngn2 misexpression alone. With the present method, the cells maintained a high neuronal differentiation rate while exhibiting increased gene expression of neuronal maturation markers, spontaneous calcium oscillation, and high electrical activity with network bursts as assessed by a multipoint electrode system. Moreover, when applying this method to iPSCs from Alzheimer’s disease (AD) patients with presenilin-1 (PS1) or presenilin-2 (PS2) mutations, cellular phenotypes such as increased amount of extracellular secretion of amyloid β42, abnormal oxygen consumption, and increased reactive oxygen species in the cells were observed in a shorter culture period than those previously reported. Therefore, it is strongly anticipated that the induction method combining Ngn2 and miR-9/9*-124 will enable more rapid and simple screening for various types of neuronal disease phenotypes and promote drug discovery.Keywords
Funding Information
- Japan Agency for Medical Research and Development (17bm0804014h0101, 18bm0804014h0102, 19bm0804014h0103, 15bm0609003h0004, 16bm0609003h0005, 17bm0609003h0006, 17bm0804003h0001, 18bm0804003h0002, 19bm0804003h0003, 15bk0104027h003, 16bk0104016h0004, 17bk0104016h0005)
- Japan Society for the Promotion of Science (JP1710083, JP26830018)
This publication has 68 references indexed in Scilit:
- Diverse reprogramming codes for neuronal identityNature, 2018
- Striatal neurons directly converted from Huntington’s disease patient fibroblasts recapitulate age-associated disease phenotypesNature Neuroscience, 2018
- MicroRNAs Induce a Permissive Chromatin Environment that Enables Neuronal Subtype-Specific Reprogramming of Adult Human FibroblastsCell Stem Cell, 2017
- Differential gene expression profiles in neurons generated from lymphoblastoid B-cell line-derived iPS cells from monozygotic twin cases with treatment-resistant schizophrenia and discordant responses to clozapineSchizophrenia Research, 2017
- Identification and Successful Negotiation of a Metabolic Checkpoint in Direct Neuronal ReprogrammingCell Stem Cell, 2015
- MicroRNA-based conversion of human fibroblasts into striatal medium spiny neuronsNature Protocols, 2015
- Rapid Single-Step Induction of Functional Neurons from Human Pluripotent Stem CellsNeuron, 2013
- Methods for Constructing Clones for Protein Expression in Mammalian CellsPublished by Springer Science and Business Media LLC ,2011
- A more efficient method to generate integration-free human iPS cellsNature Methods, 2011
- MicroRNAs in brain development and physiologyCurrent Opinion in Neurobiology, 2009